Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

NCT05432505 | Unknown

• 1 other identifier: LTT
• Study Type: observational
• Target: 20
• Locations: 0 countries
• Sites: N/A

Brief Summary

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.

Conditions

Orthopedic Disorder

Outcome Measures

Primary Outcomes (1)

• modified HHS

  score for function of the hip

  6 months

Interventions

ligamentum teres tenodesis OTHER

Identification of ligamentum teres ligamentum teres tenodesis

Eligibility Criteria

• Age: 9 Months - 60 Months
• Sex: all
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

The patients will be examined for: 1. Length of both lower limbs in relation to each other. 2. Length of both lower limbs according to patient age. 3. Presence of hump related to the outer surface of the hip 4. Presence of pain, abnormal gait, Trendlenburg test Radiographic evaluation (antero posterior and frog pelvis views) An addition to the steps of the open reduction, the following were done: 1. Identification of ligamentum teres 2. ligamentum teres tenodesis

You may qualify if:

• Patient with Developmental dysplasia of the hip (DDH) with :
• Age: from 9 months -5 years old.
• Virgin DDH.
• Failed closed reduction in the management of DDH.
• Failed open reduction through medial approach in the management of DDH

You may not qualify if:

• Paralytic hip dislocation .
• Post septic hip dislocation.
• Traumatic hip dislocation .
• Age : below 9 months or above 5 years.
• Refusal to participate in this study.

Sponsors & Collaborators

• Al-Azhar University: lead

Related Publications (2)

• Zhang S, Doudoulakis KJ, Khurwal A, Sarraf KM. Developmental dysplasia of the hip. Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-8. doi: 10.12968/hmed.2020.0223. Epub 2020 Jul 6.

  PMID: 32730146 BACKGROUND

• Schaeffer EK, Study Group I, Mulpuri K. Developmental dysplasia of the hip: addressing evidence gaps with a multicentre prospective international study. Med J Aust. 2018 May 7;208(8):359-364. doi: 10.5694/mja18.00154.

  PMID: 29716513 BACKGROUND

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 21, 2022
• First Posted: June 27, 2022
• Study Start: July 21, 2022
• Primary Completion: January 1, 2023
• Study Completion: February 1, 2023
• Last Updated: June 27, 2022

Record last verified: 2022-06